Viking Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts that cover Viking Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $99.56, which forecasts a 216.31% increase in the stock price over the next year. The lowest target is $38 and the highest is $125.

Price Target: $99.56 (+216.31%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$38	$99.56	$102	$125
Change	+20.73%	+216.31%	+224.07%	+297.14%

Analyst Ratings

The average analyst rating for Viking Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	7	7	7	5	4	5
Buy	5	5	5	3	3	3
Hold	2	2	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	14	14	10	8	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeet Mukherjee BTIG	BTIG	Strong Buy Reiterates $125	Strong Buy	Reiterates	$125	+297.14%	May 1, 2026
Steve Seedhouse Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $105 → $100	Buy	Maintains	$105 → $100	+217.71%	Apr 30, 2026
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $102	Strong Buy	Reiterates	$102	+224.07%	Mar 23, 2026
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $106 → $107	Strong Buy	Maintains	$106 → $107	+239.95%	Nov 12, 2025
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Initiates $106	Strong Buy	Initiates	$106	+236.78%	Oct 29, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-4.33

from -3.19

EPS Next Year

-4.68

from -4.33

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-0.71	-0.90	-0.91	-1.01	-3.19	-4.33	-4.68
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	21	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-2.89	-2.33
Avg	-4.33	-4.68
Low	-5.61	-6.56

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.